Laboratory diagnosis of von Willebrand disorder: Current practice in the southern hemisphere

American Journal of Clinical Pathology

Volumn 119, Issue 6, 2003, Pages 882-893

  Favaloro, Emmanuel J ^a   Bonar, Roslyn ^b   Sioufi, John ^b   Hertzberg, Mark ^b   Street, Alison ^b   Lloyd, John ^b   Marsden, Katherine ^b  

^a Sydney West Area Health Service NSW Health   (Australia)

^b NONE

Author keywords

Diagnostic practice; Hemostasis testing; Laboratory assessment; Quality control; Survey; von Willebrand disease; von Willebrand disorder; von Willebrand factor; vWD; vWF

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR; ANTIGEN; COLLAGEN; LATEX; VON WILLEBRAND ANTIGEN;

ASSAY; AUSTRALIA; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HONG KONG; HUMAN; INDIA; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LABORATORY TEST; MALAYSIA; NEW ZEALAND; OMAN; PERFORMANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SINGAPORE; SOUTH AFRICA; VON WILLEBRAND DISEASE; ARTICLE; BLOOD; CLASSIFICATION; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; MACROMOLECULE; METABOLISM; QUALITY CONTROL; REPRODUCIBILITY; STANDARD;

ANTIGENS; COLLAGEN; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIII; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOASSAY; LABORATORY TECHNIQUES AND PROCEDURES; LATEX; MACROMOLECULAR SUBSTANCES; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 85047688639     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/8WVANM7H0DKTGB9F     Document Type: Review

References (21)

1. Sadler JE, Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84:160-174.
2. Sadler JE, Gralnick HR. Commentary: a new classification for von Willebrand disease. Blood. 1994;84:676-679.
3. Sadler JE, for the Subcommittee on von Willebrand Factor of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. A revised classification of von Willebrand disease. Thromb Haemost. 1994;71:520-525.
4. Ruggeri ZM. Structure and function of von Willebrand factor. Thromb Haemost. 1999;82:576-584.
5. Favaloro EJ. Appropriate laboratory assessment as a critical facet in the proper diagnosis and sub-classification of von Willebrand's disorder. Baillieres Best Pract Res Clin Haematol. 2001;14:299-319.
6. Favaloro EJ. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease. Blood Rev. 1999;13:185-204.
7. Favaloro EJ. von Willebrand factor (vWF) collagen binding (activity) assay (vWF:CBA) in the diagnosis of von Willebrand's disorder (vWD): a 15-year journey. Semin Thromb Hemost. 2002;28:191-202.
8. Favaloro EJ. Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations. Haemophilia. 2001;7:170-179.
9. Favaloro EJ. Clinical utility of the PFA-100. Curr Opin Hematol. 2002;9:407-415.
10. Favaloro EJ, Smith J, Petinos P, et al, for the RCPA Quality Assurance Program in Haematology Scientific Haemostasis Advisory Panel. Laboratory testing, diagnosis and management of von Willebrand disease: current practice in Australasia. Am J Clin Pathol. 1999;112:712-719.
11. Favaloro EJ, Smith J, Petinos P, et al, for the RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. Thromb Haemost. 1999;82:1276-1282.
12. Favaloro EJ, Thom J, Baker R, for the Australasian Society for Thrombosis and Haemostasis Emerging Technologies Group. Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi-laboratory survey. Blood Coagul Fibrinolysis. 2000;11:729-738.
13. Arkin CF, Bowue EJW, Carroll JJ, et al. Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays; Approved Guideline. 3rd ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 1998.
14. Favaloro EJ, Nair SC, Forsyth CJ. Collection and transport of samples for laboratory testing in von Willebrand's disease (vWD): time for a reappraisal [letter]? Thromb Haemost. 2001;86:1589-1590.
15. Farrugia A, Street A, Douglas S, et al. Stabilization of von Willebrand factor in banked blood by leucocyte depletion. Transfus Med. 1993;3:51-57.
16. Lloyd JV, Tunbridge LJ, Rodgers SE, et al. Destruction of ristocetin cofactor by coagulation at 4°C. Thromb Res. 1985;37:659-667.
17. Veyradier A, Fressinaud E, Sigaud M, et al. A new automated method for von Willebrand factor antigen measurement using latex particles. Thromb Haemost. 1999;81:320-321.
18. Favaloro EJ, Aboud M, Arthur C. Possibility potential vWD misdiagnosis or misclassification using LIA technology and due to presence of rheumatoid factor. Am J Hematol. 2001;66:53-56.
19. Casonato A, Pontara E, Bertomoro A, et al. von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin cofactor activity? Br J Haematol. 2001;112:578-583.
20. Favaloro EJ. A duplex issue: (i) time to re-appraise the diagnosis and classification of von Willebrand disorder, and (ii) clarification of the roles of von Willebrand factor collagen binding and ristocetin cofactor activity assays [letter]. Haemophilia. 2002;8:828-831.
21. Montgomery RR. Minutes of the meeting of the ISTH Scientific and Standardisation Committee on vWF; July 19, 2002; Boston, MA. Available at: http://www.med.unc.edu/isth/02sscminutes/02vwf.html. Accessed November 27, 2002.